Related Experiment Video

Updated: Aug 16, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1

G L Clayman1, T J Liu, S M Overholt

  • 1Department of Head and Neck Surgery, University of Texas M. D. Anderson Cancer Center, Houston, USA.

Archives of Otolaryngology--Head & Neck Surgery
|May 1, 1996
PubMed
Abstract

Insights

Wild-type p53 adenovirus demonstrated significant tumor suppressor activity against head and neck squamous cell carcinoma in vitro and in vivo. This effect was independent of WAF1/CIP1 (p21) induction, suggesting p53

Area of Science:

  • Oncology
  • Gene Therapy
  • Molecular Biology

Background:

  • Squamous cell carcinoma of the head and neck (HNSCC) is a significant health concern.
  • Gene therapy offers a potential therapeutic avenue for HNSCC.
  • The roles of wild-type p53 and WAF1/CIP1 (p21) in HNSCC require further elucidation.

Purpose of the Study:

  • To compare the efficacy of wild-type p53 and WAF1/CIP1 (p21) gene therapy in HNSCC.
  • To evaluate the in vitro and in vivo tumor suppressor activity of these agents.

Main Methods:

  • Adenoviral vectors encoding wild-type p53 or WAF1/CIP1 (p21) were used.
  • Gene expression was confirmed via Western blot analysis.
  • In vitro cell growth and in vivo xenograft models were employed to assess therapeutic efficacy.

Main Results:

  • Wild-type p53 adenovirus significantly inhibited HNSCC cell growth in vitro.
  • Both p53 and p21 adenoviruses induced WAF1/CIP1 protein expression.
  • Repeated administration of wild-type p53 adenovirus reduced established tumor size in vivo.

Conclusions:

  • Wild-type p53 adenovirus exhibits significant in vitro and in vivo tumor suppressor activity in HNSCC.
  • The observed tumor suppression by p53 is not mediated by WAF1/CIP1 (p21) induction.
  • Further research into p53-induced apoptosis in HNSCC gene therapy is warranted.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...